Focused on the unmet medical needs of patients in South East Asia, Australia and New Zealand
Federal Treasurer Josh Frydenberg opens new ST headquarters
Political heavyweight praises ST innovation...
Our CEO discusses the last decade and reveals future plans
Pharma industry authority Paul Cross talks with Carlo Montagner...
New Concept: ST sponsors major scientific award.
New research into the potential benefit of immunotherapy of immunotherapy in pan...
Exercise and Pancreatic Cancer: Expert Guidelines
Exercise can halt, or even reverse the decline of function and energy that commo...
Our Philanthropic Heart
Our CEO is in Africa with Specialists Without Borders...
10 Years of Meeting Unmet Needs: A testimonial
Rare Cancers Australia Chief Executive Richard Vines discusses STA...
10 Years of Giving: Our Commitment to Global Health
ST is committed to leaving an enduring legacy....
10 Years of Partnering
Our partner PharmaMar offers this insight...
10 Years of Innovation: How we set a new benchmark
STA prides itself on being innovative and entrepreneurial. We set a new pharma i...
TAILORx Explained
Australian oncologist Ric de Boer discusses TAILORx and Oncotype DX...
Access Program Initiated
The following article by Sarah-Jane Tasker has appeared in The Australian...